Roche buys full control of health tech start-up Flatiron for $1.9 billion

Swiss pharma giant Roche (ROG: SIX) has signed a definitive agreement under which it will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6% via an investment of $175 million in 2016.

Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, USA, is a market leader in oncology-specific electronic health record (EHR) software, as well as the curation and development of real-world evidence for cancer research. With its large network of community oncology practices and academic medical centers across the USA, Flatiron Health has created a technology platform designed to learn from the experience of every patient.

Flatiron will continue its current business model